Orbus Therapeutics Granted European Patent for Method of Use for Eflornithine
September 28, 2021 10:00 ET
|
Orbus Therapeutics, Inc.
- Patent relates to method for use of eflornithine to treat cancers, including gliomas - PALO ALTO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Orbus Therapeutics Inc., a private, late-stage...